Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
VisualSonics Targets the Preclinical Area
Company's High-resolution, In situ Imaging Method Provides Real-time, Noninvasive Tool
- VisualSonics (www.visualsonics.com) markets and develops high-resolution, micro-ultrasound imaging systems to life science researchers worldwide. The company launched its Vevo™ micro-ultrasound platform in 2003. By 2005, VisualSonics had sold over 200 systems, experienced a 145% compounded annual growth rate, reached $24 million in annualized sales, and obtained ISO 9001:2000 registration. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.